Chemed CHE
$548.59 −$2.74 (-0.50%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $548.70 +0.02%
Open$556.34
Prev close$551.33
Day range$545.36 – $559.90
Volume160.2K
Market cap$7.11B
P/E (TTM)26.3
Dividend yield0.46%
CHE Stock News
Headlines matching Chemed or the CHE ticker, most recent first.
- UBS Initiates Chemed(CHE.US) With Buy Rating, Announces Target Price $650
- The court has accepted the bankruptcy liquidation application for Che Dian Wang, an associate company of Shenzhen CLP Electronics (002121.SZ). Negative
- RBC Capital Remains a Buy on Chemtrade Logistics (CHE.UN)
- BofA Securities Maintains Chemed(CHE.US) With Hold Rating, Announces Target Price $550
- SANCY: Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR IZHAR BIN CHE MEE
- Yuanguang Technology (02605) announced its interim results for 2026, reporting a significant narrowing of net losses. By focusing on user experience, the company drove an approximately 8.4% increase in the rating of its flagship app, "Che Laile," across m Negative
- Four Rings Medicine (00460.HK) appointed Che Yuxuan as a non-executive director and Song Xiaomi as Chief Financial Officer.
- Chemtrade Logistics (CHE.UN) Gets a Buy From RBC Capital
- CIBC Sticks to Their Buy Rating for Chemtrade Logistics (CHE.UN)
- BofA Securities Downgrades Chemed(CHE.US) to Hold Rating, Cuts Target Price to $510 Negative
- Oppenheimer Maintains Chemed(CHE.US) With Buy Rating, Raises Target Price to $590 Positive
- BofA Securities Maintains Chemed(CHE.US) With Hold Rating
- RBC Capital Maintains Chemed(CHE.US) With Hold Rating, Raises Target Price to $548 Positive
- ARTRONIQ: Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - ENCIK MOHAMED FARIS BIN CHE LODIN (Amended Announcement)
- ARTRONIQ: Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - ENCIK MOHAMED FARIS BIN CHE LODIN
No comments yet — be the first to weigh in on CHE.
Sign in to join the discussion.